Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD.

Nutrients - 7 Jun 2024

Satthawiwat Nantawat, Jinato Thananya, Sutheeworapong Sawannee, Tanpowpong Natthaporn, Chuaypen Natthaya, Tangkijvanich Pisit

Abstract excerpt

Gut microbiota might affect the severity and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to characterize gut dysbiosis and clinical parameters regarding fibrosis stages assessed by magnetic resonance elastography. This study included 156 patients with MASLD, stratified into no/mild fibrosis (F0-F1) and moderate/severe fibrosis (F2-F4). Fecal specimens were sequenced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 17-Hydroxysteroid Dehydrogenases
Share to Acyltransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dysbiosis

Share to Elasticity Imaging Techniques

Share to Fatty Liver

Share to Gastrointestinal Microbiome

Share to Lipase

Share to Phospholipases A2, Calcium-Independent

Source

Open in PubMed Open full text

Identifiers

PMID: 38931155
DOI: 10.3390/nu16121800
PMCID: PMC11206871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD.PMID 38931155Read ↗

Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome dataSemantic proximity Read ↗

Liver microbiome composition associates with histological severity and PNPLA3 genotype in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read ↗

Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity Read ↗

Comparison of gut microbiota in male MAFLD patients with varying liver stiffnessSemantic proximity Read ↗

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read ↗

Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotype.Semantic proximity Read ↗

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Semantic proximity Read ↗

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patientsSemantic proximity Read ↗

The influence of host genetics on liver microbiome composition in patients with NAFLD.Semantic proximity Read ↗

Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.